Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2000
02/10/2000WO1999058139A3 Methods for detecting and inhibiting angiogenesis
02/10/2000WO1999053908A3 Pro-drug conjugates for the treatment of stroke and other ischaemic conditions
02/10/2000WO1999045910A3 Methods and compositions for treating and preventing mucositis
02/10/2000WO1999030548A3 Method for the preparation of citalopram
02/10/2000WO1999023104A3 Antitumour uridine analogues
02/10/2000WO1999015161A3 Inhibition of psychostimulant-induced and nicotine-induced craving
02/10/2000DE19835918A1 Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung New anticonvulsant action of 4-amino-1-aryl-pyridin-2-one and processes for their preparation
02/10/2000DE19835850A1 Verwendung von Hemmstoffen der HMG-CoA-Reduktase zur Senkung des Cholesteringehaltes in Geflügelei The use of inhibitors of HMG-CoA reductase to reduce the cholesterol content in poultry egg
02/10/2000DE19835611A1 Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten Novel synthetic phospholipids with unsaturated alkyl and acyl chains
02/10/2000DE19835325A1 Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten Use of cyclopentabenzofuran derivatives for the control of NF-kB-dependent diseases
02/10/2000DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use
02/10/2000CA2581111A1 Rapidly disintegrable solid preparation
02/10/2000CA2525555A1 Rapidly disintegrable solid preparation
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339233A1 Inhibitors of redox signaling and methods of using same
02/10/2000CA2339125A1 Novel chitosan-containing liquid compositions and methods for their preparation and use
02/10/2000CA2339099A1 Sulfonamide derivatives
02/10/2000CA2339094A1 Macrophage scavenger receptor antagonists
02/10/2000CA2339093A1 Cholinergic agents in the treatment of presbyopia
02/10/2000CA2339091A1 Sulphonamide derivatives
02/10/2000CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000CA2338930A1 Heterocyclic sulphonamide derivatives
02/10/2000CA2338916A1 Amide, carbamate, and urea derivatives
02/10/2000CA2338912A1 Medicine nitrate salts
02/10/2000CA2338864A1 Sulphonamide derivatives
02/10/2000CA2338861A1 Estradiol-containing patch for transdermal administration of hormones
02/10/2000CA2338825A1 Lipid-lowering quinazoline derivative
02/10/2000CA2338806A1 Composition for freshening nostrils and sinus cavities
02/10/2000CA2338804A1 Propenamides as ccr5 modulators
02/10/2000CA2338797A1 Hair growth/maintenance compositions and methods involving the same
02/10/2000CA2338785A1 Use of xanthophyll to accentuate the effects of estrogen
02/10/2000CA2338764A1 Substituted anilide compounds and methods
02/10/2000CA2338745A1 Heterocyclyl sulphonamide derivatives
02/10/2000CA2338740A1 Treatment of anxiety disorders
02/10/2000CA2338706A1 Sustained release nitric oxide producing agents
02/10/2000CA2338705A1 Methods and compositions to treat glycosaminoglycan-associated molecular interactions
02/10/2000CA2338697A1 Compounds and methods
02/10/2000CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
02/10/2000CA2338654A1 Triazolopyridines for the treatment of thrombosis disorders
02/10/2000CA2338558A1 Use of biogenic estrogen sulfamates for hormone replacement therapy
02/10/2000CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases
02/10/2000CA2338465A1 Methods and compositions for treating gastro-esophageal reflux disease
02/10/2000CA2338396A1 Ultrasonic enhancement of drug injection
02/10/2000CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders
02/10/2000CA2338327A1 Use of moclobemide for treating pain and other diseases
02/10/2000CA2338326A1 Use of moclobemide and metabolites for treating and preventing substance abuse
02/10/2000CA2338298A1 Tricyclic compounds
02/10/2000CA2338275A1 Integrin receptor antagonists
02/10/2000CA2337710A1 Autoinducer synthase modulating compounds and uses therefor
02/10/2000CA2337690A1 Chemically induced intracellular hyperthermia
02/10/2000CA2337102A1 Nucleic acids and proteins from group b streptococcus
02/10/2000CA2336802A1 Substituted quinazoline derivatives
02/10/2000CA2336549A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000CA2336543A1 Isoforms of human calcium sensing receptor
02/10/2000CA2336536A1 Growth differentiation factor-11
02/10/2000CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000CA2335643A1 C7f2-a novel potassium channel .beta.-subunit
02/10/2000CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/10/2000CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods
02/10/2000CA2304881A1 Topical compositions containing sialyl sugars and their derivatives
02/09/2000EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression
02/09/2000EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments
02/09/2000EP0978515A2 1-(substituted phenyl)-4-biphenylmethyl-imidazol-2-one derivatives, their preparation and their use as angiotensin II antagonists
02/09/2000EP0978289A1 Virucide drug containing iodine
02/09/2000EP0978288A1 Medicinal composition
02/09/2000EP0978284A1 Endothelin antagonist
02/09/2000EP0978283A1 Manufacture of an agent inhibiting transplant rejection
02/09/2000EP0978282A2 Sublingual composition containing apomorphine for diagnosing functional impotence
02/09/2000EP0978281A1 Eyedrops
02/09/2000EP0978279A1 Inhibitors of human glycogen phosphorylase
02/09/2000EP0978278A1 Diabetes remedies
02/09/2000EP0978277A1 Antirheumatic agents
02/09/2000EP0978276A2 Polymer coated tablet comprising amoxycillin and clavunalate
02/09/2000EP0978274A2 Emulsifier and emulsified composition
02/09/2000EP0978236A1 The use of cholesterol-synthesis inhibitors for the reduction of the level of cholesterol in bird eggs
02/09/2000EP0977993A1 Cadherin-11 as an indicator of viable pregnancy
02/09/2000EP0977892A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
02/09/2000EP0977887A2 Member of the tnf family useful for treatment and diagnosis of disease
02/09/2000EP0977880A2 Materials and methods for treatment of retinal diseases
02/09/2000EP0977855A2 Polypeptides associated with activator receptors and their biological applications
02/09/2000EP0977849A1 Leukemia associated genes
02/09/2000EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors
02/09/2000EP0977841A2 Materials and methods for ribozyme treatment of retinal diseases
02/09/2000EP0977834A2 Human serine protease precursor
02/09/2000EP0977815A1 ALKYL, ALKENYL AND ALKYNYL CHRYSAMINE G DERIVATIVES FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND $i(IN VIVO) IMAGING AND PREVENTION OF AMYLOID DEPOSITION
02/09/2000EP0977777A1 A novel th2-specific gene
02/09/2000EP0977767A1 Aminooxy-modified oligonucleotides
02/09/2000EP0977759A1 Crf antagonistic thiophenopyridines
02/09/2000EP0977758A1 Spiro-azacyclic derivatives and their use as therapeutic agents
02/09/2000EP0977757A1 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity
02/09/2000EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
02/09/2000EP0977755A1 Heterocyclic compounds and their preparation and use
02/09/2000EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
02/09/2000EP0977751A1 Somatostatin agonists
02/09/2000EP0977750A1 Farnesyltransferase inhibiting quinazolinones
02/09/2000EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
02/09/2000EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation
02/09/2000EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds
02/09/2000EP0977743A1 Protease inhibitors
1 ... 6366 6367 6368 6369 6370 6371 6372 6373 6374 6375 6376 6377 6378 6379 6380 6381 6382 6383 6384 6385 6386 ... 7860